Showing results (891-900 of 1,120) with videos related to
Sort By:
Pageof 112
Circulation|May 4, 2013
Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillationLars Wallentin, Renato D Lopes, Michael Hanna, et al.Circulation|November 6, 2022
Survival After Invasive or Conservative Management of Stable Coronary DiseaseJudith S Hochman, Rebecca Anthopolos, Harmony R Reynolds, et al.JACC. Cardiovascular Imaging|September 17, 2022
Ischemia With Nonobstructive Coronary Arteries: Insights From the ISCHEMIA TrialHarmony R Reynolds, Ariel Diaz, Derek D Cyr, et al.Lancet (London, England)|November 9, 2015
Effect of the REG1 anticoagulation system versus bivalirudin on outcomes after percutaneous coronary intervention (REGULATE-PCI): a randomised clinical trialA Michael Lincoff, Roxana Mehran, Thomas J Povsic, et al.Circulation|September 27, 2019
Antithrombotic Therapy in Patients With Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or With Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention: Insights From the AUGUSTUS TrialStephan Windecker, Renato D Lopes, Tyler Massaro, et al.American Heart Journal|February 23, 2025
Effects of carvedilol on the prevention of cardiotoxicity induced by anthracyclines: Design and rationale of the CARDIOTOX trialIsabela Bispo Santos da Silva Costa, Remo H M Furtado, Luciano F Drager, et al.Thrombosis Research|August 25, 2023
Enoxaparin for symptomatic COVID-19 managed in the ambulatory setting: An individual patient level analysis of the OVID and ETHIC trialsStefano Barco, Saverio Virdone, Andrea Götschi, et al.CJC Open|March 7, 2022
The Anti-Coronavirus Therapies (ACT) Trials: Design, Baseline Characteristics, and ChallengesJohn Eikelboom, Sumathy Rangarajan, Sanjit S Jolly, et al.Journal of Thrombosis and Thrombolysis|May 7, 2011
Highlights from the III International Symposium of Thrombosis and Anticoagulation (ISTA), October 14-16, 2010, São Paulo, BrazilRenato D Lopes, Richard C Becker, John H Alexander, et al.The New England Journal of Medicine|August 30, 2011
Apixaban versus warfarin in patients with atrial fibrillationChristopher B Granger, John H Alexander, John J V McMurray, et al.Pageof 112